Zweiman B. (1989) Theoretical mechanisms by which immunoglobulin therapy might benefit myasthenia gravis . Clin iImmunol Immunopathol53: 583-591.
2.
Sandor et al. (1990) CD4+ murine T cell clones that express high levels of immunoglobulin binding belong to the interleukin-4-producing T helper cell type 2 subset . J Exp Med171: 2171- 2176.
3.
Sandor et al. (1992) In vitro and in vivo activation of murine γ/6 T cells induce the expression of IgA, IgM, and IgG Fc receptors . J Immunol148: 2363-2369.
4.
Maynier M. , Cosso B. , Brochier J. , Clot J. ( 1987) Identification of class II HLA alloantibodies in placenta-eluted gamma globulin used for treating rheumatoid arthritis . Arthr Rheumat30: 375-381.
5.
Wurster U. , Haas J. ( 1994) Passage of intravenous immunoglobulin and interaction with the CNS . J Neurol Neurosurg Psychiatry57(suppl): 21-35.
6.
Rodiguez M. , Lennon VA (1990) Immunoglobulins promote remyelination in the central nervous system . Ann Neurol27: 12 -17.
7.
Rodriguez M. (1991) Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells . Lab Invest64: 358-370.
8.
Lemire JM , Weigle WO (1986) Myelin basic protein-specific T cell clones and experimental allergic encephalomyelitis . Pathol Immunopathol Res5: 248-252.
9.
Mokhatarian VF , McFarlin DE , Raine CS (1984) Adoptive transfer of myelin basic protein-synthesized T cells produce chronic relapsing demyelinating disease in mice . Nature309: 356-358.
10.
Achiron A. et al. (1994) Intravenous immunoglobulin treatment of experimental T-cell mediated autoimmune diseases: Up-regulation of T cell proliferation and downregulation of TNF-α secretion . J Clin Invest93: 600-605.
11.
Achiron A. et al. (1994) Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune diseases: delineation of usage and mode of action . J Neurol Neurosurg Psychiatry57(suppl): 57-61.
12.
Rotherfelder U. , Neu I. , Pelka R. (1982) Therapy for multiple sclerosis with immunoglobulin G . Munch Med Wochenschr124: 74-78.
13.
Schuller E. , Govaerts A. (1983) First results of immunotherapy with immunoglobulin G in multiple sclerosis patients . Eur Neurol22: 205 - 212.
14.
Soukop W. , Tschabitscher H. (1986) Gamma globulin therapy in multiple sclerosis. Theoretical considerations and initial clinical experience with 7S immunoglobulins in MS therapy . Wien Med Wochenschr136: 477-480.
15.
Achiron et al. (1992) Open controlled therapeutic trial of high-dose intravenous immunoglobulins in relapsing-remitting multiple sclerosis . Arch Neurol49: 1233-1236.
16.
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology33: 1444 -1452.
17.
Achiron A. et al. (1996) Intravenous immunoglobulin in multiple sclerosis: clinical and neuroradiologic results and implications for possible mechanisms of action . Clin Exp Immunol104(suppl 1): 67-70.
18.
Korn-Lubetzki I. , Kahana E. , Cooper G. , Abramsky O. (1984) Activity of multiple sclerosis during pregnancy and puerperium . Ann Neurol16: 228-231.
19.
Birk K. et al. (1990) The clinical course of multiple sclerosis during pregnancy and the puerperium . Arch Neurol47: 738 - 742.
20.
Achiron A. et al. (1996) Intravenous immunoglobulin treatment in the prevention of childbirth associated acute exacerbations in multiple sclerosis-A pilot study . J Neurol243: 25 - 28.
21.
Achiron A. et al. (1996) Intravenous immunoglobulin in multiple sclerosis: A multicenter, double-blind, placebo-controlled trial . Neurology46(suppl): A405 -406.
